Search Results

There are 781872 results for: content related to: Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment

  1. You have free access to this content
    Upregulation of the TGFβ signalling pathway by Bcr-Abl: Implications for haemopoietic cell growth and chronic myeloid leukaemia

    FEBS Letters

    Volume 581, Issue 7, April 03, 2007, Pages: 1329–1334, Gigi M.O. Møller, Victoria Frost, Junia V. Melo and Andrew Chantry

    Version of Record online : 1 MAR 2007, DOI: 10.1016/j.febslet.2007.02.048

  2. Leukemic kinases of the Abl family − an update

    Signal Transduction

    Volume 1, Issue 1-2, November 2001, Pages: 11–36, Jan Voss, Nora Heisterkamp, John Groffen and Stephan M. Feller

    Version of Record online : 7 NOV 2002, DOI: 10.1002/1615-4061(200111)1:1/2<11::AID-SITA11>3.0.CO;2-N

  3. You have free access to this content
    TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis

    The EMBO Journal

    Volume 17, Issue 15, August 3, 1998, Pages: 4442–4455, Danilo Perrotti, Silvia Bonatti, Rossana Trotta, Robert Martinez, Tomasz Skorski, Paolo Salomoni, Emanuela Grassilli, Renato V. Iozzo, Denise R. Cooper and Bruno Calabretta

    Version of Record online : 3 AUG 1998, DOI: 10.1093/emboj/17.15.4442

  4. You have free access to this content
    Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway

    The EMBO Journal

    Volume 16, Issue 20, October 15, 1997, Pages: 6151–6161, Tomasz Skorski, Alfonso Bellacosa, Margaret Nieborowska-Skorska, Miroslaw Majewski, Robert Martinez, John K. Choi, Rossana Trotta, Pawel Wlodarski, Danilo Perrotti, Tung O. Chan, Mariusz A. Wasik, Philip N. Tsichlis and Bruno Calabretta

    Version of Record online : 15 OCT 1997, DOI: 10.1093/emboj/16.20.6151

  5. You have free access to this content
    Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein

    American Journal of Hematology

    Volume 88, Issue 6, June 2013, Pages: 455–462, Baukje M. Elzinga, Michelle J. Nyhan, Lisa C. Crowley, Tracey R. O'Donovan, Mary R. Cahill and Sharon L. McKenna

    Version of Record online : 2 APR 2013, DOI: 10.1002/ajh.23428

  6. You have full text access to this Open Access content
    Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors

    STEM CELLS Translational Medicine

    Volume 3, Issue 4, April 2014, Pages: 405–415, Christine Victoria Ichim

    Version of Record online : 5 MAR 2014, DOI: 10.5966/sctm.2012-0159

  7. You have free access to this content
    Bcr-Abl upregulates cytosolic p21WAF-1/CIP-1 by a phosphoinositide-3-kinase (PI3K)-independent pathway

    British Journal of Haematology

    Volume 123, Issue 1, October 2003, Pages: 34–44, Karen Keeshan, Thomas G. Cotter and Sharon L. McKenna

    Version of Record online : 26 SEP 2003, DOI: 10.1046/j.1365-2141.2003.04538.x

  8. You have full text access to this Open Access content
    Molecular biology of chronic myeloid leukemia

    Cancer Science

    Volume 103, Issue 9, September 2012, Pages: 1601–1610, Yoshiro Maru

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1349-7006.2012.02346.x

  9. Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia

    Journal of Cellular Biochemistry

    Volume 113, Issue 8, August 2012, Pages: 2765–2774, Manuela Mancini, Nevena Veljkovic, Elisa Leo, Michela Aluigi, Enrica Borsi, Chiara Galloni, Ilaria Iacobucci, Enza Barbieri and Maria Alessandra Santucci

    Version of Record online : 15 JUN 2012, DOI: 10.1002/jcb.24154

  10. You have free access to this content
    Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

    British Journal of Haematology

    Volume 107, Issue 3, December 1999, Pages: 587–599, Branford, Hughes and Rudzki

    Version of Record online : 3 OCT 2008, DOI: 10.1046/j.1365-2141.1999.01749.x

  11. You have free access to this content
    Chronic myelogenous leukaemia with p185BCR/ABL expression: characteristics and clinical significance

    British Journal of Haematology

    Volume 107, Issue 3, December 1999, Pages: 581–586, Farhad Ravandi, Jorge Cortes, Maher Albitar, Ralph Arlinghaus, Jie Qiang Guo, Moshe Talpaz and Hagop M. Kantarjian

    Version of Record online : 3 OCT 2008, DOI: 10.1046/j.1365-2141.1999.01736.x

  12. You have full text access to this Open Access content
    Stem cell and kinase activity-independent pathway in resistance of leukaemia to BCR-ABL kinase inhibitors

    Journal of Cellular and Molecular Medicine

    Volume 11, Issue 6, November/December 2007, Pages: 1251–1262, Shaoguang Li and Dongguang Li

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1582-4934.2007.00108.x

  13. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Current Treatment Status and Perspectives

    Leukemias: Principles and Practice of Therapy

    Olga Sala-Torra, Jerald P. Radich, Pages: 228–243, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch18

  14. You have free access to this content
    Consequences of BCR-ABL Expression within the Hematopoietic Stem Cell in Chronic Myeloid Leukemia

    STEM CELLS

    Volume 18, Issue 6, November 2000, Pages: 399–408, Janusz H. S. Kabarowski and Owen N. Witte

    Version of Record online : 1 NOV 2000, DOI: 10.1002/stem.180399

  15. You have full text access to this Open Access content
    Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 8b, August 2009, Pages: 2039–2052, Zhi Hong Fang, Chun Lan Dong, Zhong Chen, Bin Zhou, Na Liu, Hai Feng Lan, Lu Liang, Wen Bin Liao, Lei Zhang and Zhong Chao Han

    Version of Record online : 13 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00549.x

  16. Do we need more drugs for chronic myeloid leukemia?

    Immunological Reviews

    Volume 263, Issue 1, January 2015, Pages: 106–123, Tessa L. Holyoake and G. Vignir Helgason

    Version of Record online : 15 DEC 2014, DOI: 10.1111/imr.12234

  17. You have free access to this content
    Targeting survival pathways in chronic myeloid leukaemia stem cells

    British Journal of Pharmacology

    Volume 169, Issue 8, August 2013, Pages: 1693–1707, A Sinclair, A L Latif and T L Holyoake

    Version of Record online : 26 JUL 2013, DOI: 10.1111/bph.12183

  18. You have free access to this content
    Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

    European Journal of Haematology

    Volume 87, Issue 5, November 2011, Pages: 381–393, Shantashri Vaidya, Kanjaksha Ghosh and Babu Rao Vundinti

    Version of Record online : 2 OCT 2011, DOI: 10.1111/j.1600-0609.2011.01689.x

  19. New insights into small-molecule inhibitors of Bcr-Abl

    Medicinal Research Reviews

    Volume 31, Issue 1, January 2011, Pages: 1–41, S. Schenone, O. Bruno, M. Radi and M. Botta

    Version of Record online : 27 AUG 2009, DOI: 10.1002/med.20175

  20. Identification of transcriptional targets associated with the expression of p210 Bcr-Abl

    European Journal of Haematology

    Volume 76, Issue 5, May 2006, Pages: 369–383, Fionnuala B. Hickey and Thomas G. Cotter

    Version of Record online : 23 FEB 2006, DOI: 10.1111/j.1600-0609.2006.00629.x